Immunotherapy side effects under the microscope: MOTIVATE study tracks 150 patients

NCT ID NCT03447483

Completed Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 150 people with solid tumors who were starting immunotherapy (immune checkpoint inhibitors) as part of their regular care. Researchers collected data on side effects and asked patients to fill out questionnaires before each treatment. The goal was to better understand how and when side effects appear, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

CH ALBI

Albi, France
Ch Castres

Castres, France
Hopital Larrey

Toulouse, 31059, France
Institut Curie

Paris, 75005, France
Institut Regional Du Cancer de Montpellier (Icm)

Montpellier, 34298, France
Institut Universitaire Du Cancer de Toulouse - Oncopole

Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.